1-3 of 3
Ulrike Söling
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Proof of Y-Loss As Clonal Abnormality in MDS by Comparative Analysis of CD34+ and CD3+ Peripheral Blood Cells,

Christina Ganster, Friederike Braulke, Katayoon Shirneshan, Dietrich Kämpfe, Uwe Platzbecker, MD, Ulrike Söling, Carsten P Bramlage, Tobias J Legler, Detlef Haase, Julie Schanz
Journal: Blood
Blood (2011) 118 (21): 3800.
https://doi.org/10.1182/blood.V118.21.3800.3800
Published: 2011
Journal Articles

Subcutaneous Alemtuzumab (Campath) in Fludarabine-Refractory CLL: Final Results of the CLL2H Trial of the GCLLSG and Comprehensive Analysis of Prognostic Markers

Stephan Stilgenbauer, Thorsten Zenz, Dirk Winkler, Andreas Bühler, Silja Groner, Raymonde Busch, Manfred Hensel, Ulrich Dührsen, Juergen Finke, Peter Dreger, Ulrich Jäger, Eva Lengfelder, Lorenz H. Truemper, Ulrike Söling, Rudolf Schlag, Michael Hallek, Hartmut Döhner
Journal: Blood
Blood (2008) 112 (11): 329.
https://doi.org/10.1182/blood.V112.11.329.329
Published: 2008
Journal Articles

Subcutaneous Alemtuzumab (MabCampath) in Fludarabine-Refractory CLL (CLL2H Trial of the GCLLSG).

Stephan Stilgenbauer, Dirk Winkler, Andreas Bühler, Thorsten Zenz, Silja Groner, Raymonde Busch, Manfred Hensel, Ulrich Dührsen, Jürgen Finke, Peter Dreger, Ulrich Jäger, Eva Lengfelder, Lorenz Trümper, Ulrike Söling, Rudolf Schlag, Michael Hallek, Hartmut Döhner
Journal: Blood
Blood (2007) 110 (11): 3120.
https://doi.org/10.1182/blood.V110.11.3120.3120
Published: 2007